Gilles de la tourette’s syndrome: Effects of stimulant drugs

Neurology

Volumn 35, Issue 9, 1985, Pages 1346-1348

  Erenberg, Gerald ^a   Cruse, Robert P ^a   Rothner, A David ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL STIMULANT AGENT; DEXAMPHETAMINE; HALOPERIDOL; METHYLPHENIDATE; PEMOLINE;

ATTENTION DEFICIT DISORDER; CENTRAL NERVOUS SYSTEM; CHILD; CLINICAL ARTICLE; DRUG COMPARISON; DRUG EFFICACY; ETIOLOGY; GILLES DE LA TOURETTE SYNDROME; HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; THERAPY; TIC;

CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; DEXTROAMPHETAMINE; HUMAN; METHYLPHENIDATE; PEMOLINE; TIC DISORDERS; TOURETTE SYNDROME;

EID: 0021876426     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.35.9.1346     Document Type: Article

References (20)

1. Golden GS. Tourette syndrome: the pediatric perspective. Am J Dis Child 1977;131:531-4.
2. Shapiro E, Shapiro AK. Tic disorders. JAMA 1981;245:1583-5.
3. Erenberg G, Cruse RP, Rothner AD. Tourette syndrome: an analysis of 200 pediatric and adolescent cases. Submitted to Cleveland Clinic Quarterly.
4. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 3rd ed. Washington: 1980:76-7.
5. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 3rd ed. Washington: 1980:41-5.
6. Meyerhoff JH, Snyder SH. Gilles de la Tourette’s disease and minimal brain dysfunction: amphetamine isomers reveal catecholamine correlates in an affected patient. Psychopharmacologia 1973;29:211-20.
7. Golden GS. Gilles de la Tourette’s svndrome followina methylphenidate administration. Dev Med Child Neurol 1974;16:76-8.
8. Denckla MB, Bemporad JR, MacKay MC. Tics following methylphenidate administration: a report of 20 cases. JAMA 1976;235:1349-51.
9. Golden GS. The effect of central nervous system stimulants on Tourette syndrome. Ann Neurol 1977;2:69-70.
10. Fras I, Karlavage J. The use of methylphenidate and imipramine in Gilles de la Tourette’s disease in children. Am J Psychiatry 1977;134:195-7.
11. Pollack MA, Cohen NL, Friedhoff AJ. Gilles de la Tourette’s syndrome: familial occurrence and precipitation by methylphenidate therapy. Arch Neurol 1977;34:630-2.
12. Feinberg M, Carroll BJ. Effects of dopamine agonists and antagonists in Tourette’s disease. Arch Gen Psychiatry 1979;369:79-85.
13. Bremness AB, Sverd J. Methylphenidate-induced Tourette syndrome: case report. Am J Psychiatry 1979;136:1334-5.
14. Mitchell E, Matthews KL. Gilles de la Tourette’s disorder associated with pemoline. Am J Psychiatry 1980;137:1618-9.
15. Sleator EK. Deleterious effects of drugs used for hyperactivity on patients with Gilles de la Tourette syndrome. Clin Pediatr 1980;19:453-4.
16. Bachman DS. Pemoline-induced Tourette’s disorder: a case report. Am J Psychiatry 1981;138:1116-7.
17. Shapiro AK, Shapiro E. Do stimulants provoke, cause, or exacerbate tics and Tourette syndrome? Compr Psychiatry 1981;22:265-73.
18. Lowe TL, Cohen DJ, Detlor J, et al. Stimulant medications precipitate Tourette’s syndrome. JAMA 1982;247:1729-31.
19. Rapoport JL, Nee L, Mitchell S, et al. Hyperkinetic syndrome and Tourette syndrome. In: Friedhoff AJ, Chase TN, eds. Advances in neurology, vol 35. Gilles de la Tourette syndrome. New York: Raven Press, 1982:423-6.
20. Cohen DJ, Detlor J, Shaywitz BA, et al. Interaction of biological and psychological factors in the natural history of Tourette syndrome: a paradigm for childhood neuropsychiatric disorders. In: Friedhoff AJ, Chase TN, eds. Advances in Neurology, vol 35. Gilles de la Tourette syndrome. New York: Raven Press, 1982:31-40.